Received: 17 October 2019
Accepted: 19 October 2020
First Online: 19 November 2020
Ethics approval and consent to participate
: All participants gave their written informed consent to participate in the research under an approved IRB # <b>STU 042011-135</b> of Dallas Regional Autoimmune Disease Registry. All research protocols and experiment methods used in this study were approved by the UT Southwestern Institutional Review Board (IRB) as well as by primary enrolling institution at each center. All experimental methods comply with the Helsinki Declaration.
: The authors declare no competing interests.